Hundreds of women could benefit from ovarian cancer drug pairing that doubles chance of remission
A new drug combination trialed by Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, was twice as effective as existing ovarian cancer treatments.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Foundation Trusts | Health | Ovarian Cancer | Ovaries | Women